Oxford Eye Surgery Read More »
Anaesthesia in glaucoma/ophthalmology Read More »
Psychology of sight loss Read More »
ECP role of manipulating inflow in age of MIGS Read More »
Ocular surface Read More »
Preservative Free treatments Read More »
MIGS controversies Read More »
Cataract surgery in glaucoma Read More »
GDD Read More »
Eye watch, the medium term success Read More »
For educating Ophthalmologists Worldwide
Laura Crawley is a consultant ophthalmologist and Head of Specialty at Imperial College Healthcare NHS Trust with specialist interests in Glaucoma & cataract surgery.
She qualified in medicine from University of Bristol in 1999, winning the Gold medal and Suple prizes for medicine and surgery.
Having completed physician training in Bristol she undertook Ophthalmology training in Oxford and then in London at Moorfields and Imperial. She won the national Alcon Glaucoma prize in 2009 and holds the Royal College of Ophthalmologists’ Treacher Collins Prize 2012 and West London Ophthalmic Research Medal 2011. She lectures widely including the UCL Ophthalmology MSc course and BMJ ‘masterclasses for GPs’ series.
She is an Honorary Senior Lecturer at Imperial College London. Her research is focused on topical glaucoma treatments and their effects on the ocular surface, micro-invasive glaucoma surgery, endocyclophotocoagulation in glaucoma management, developing strategies for managing chronic eye conditions in primary care and providing ophthalmology support for clinical trials in other sub specialties.
International Glaucoma Association Professor of Ophthalmology for Glaucoma & Allied Studies
Institute of Ophthalmology, University College London, and Moorfields Eye Hospital, London, UK
David Garway-Heath is currently President of the European Glaucoma Society. In addition to his clinical work, he leads research in visual assessment and imaging at the Biomedical Research Centre of the UK National Institute for Health Research. The ‘Garway-Heath map’ that he developed has contributed to the understanding of structure- function relationship in glaucoma and the ‘Moorfields Regression Analysis’, a diagnostic algorithm that he developed for the HRT, has led to the widespread use of imaging in glaucoma management. He conducted the first randomized placebo-controlled trial to provide evidence for visual field preservation with an IOP-lowering drug, and the study design he used for the trial enabled a considerable reduction in the period needed to identify treatment effects.
Professor Garway-Heath has been recipient of several awards and has been consecutively cited as one of the 100 most influential people in ophthalmology worldwide in The Ophthalmologist magazine’s power list. He is also Vice President of the Imaging and Perimetry Society, Chair of the Membership Committee of the Glaucoma Research Society, and Workstream Lead for the design of the new Moorfields Eye Hospital and UCL Institute of Ophthalmology centre.